RT Book, Section
A1 Wedig, Kathy E.
A2 Zaoutis, Lisa B.
A2 Chiang, Vincent W.
SR Print(0)
ID 1146121314
T1 Neonatal Abstinence Syndrome
T2 Comprehensive Pediatric Hospital Medicine, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071829281
LK accesspediatrics.mhmedical.com/content.aspx?aid=1146121314
RD 2024/04/24
AB Approximately  4.4%  of  women  of  childbearing  years  use  illicit  drugs  or  abuse  prescription  medications,  including  marijuana,  cocaine,  hallucinogens,  heroin,  sedatives,  painkillers,  and  stimulants.1  Infants  born  to  mothers  who  habitually  use  opioids  (heroin,  methadone,  morphine,  buprenorphine,  meperidine,  or  codeine)  can  have  physical  manifestations  of  opiate  withdrawal,  termed  neonatal  abstinence  syndrome  (NAS).  In  recent  years,  the  number  of  infants  diagnosed  with  NAS  nationally  has  increased  significantly,2  likely  in  part  due  to  more  liberal  use  of  prescription  opiates  during  pregnancy.3  Although  NAS  refers  specifically  to  opiate  withdrawal,  similar  symptoms  can  occur  in  infants  with  intrauterine  exposure  to  other  drugs.